Countering COVID-19 Vaccine Hesitancy in Pregnancy: the "4 Cs"

Am J Perinatol. 2022 Jul;39(10):1048-1054. doi: 10.1055/a-1673-5546. Epub 2021 Oct 19.

Abstract

Despite evidence to support the safety and efficacy of COVID-19 vaccination in pregnancy, and clear recommendations from professional organizations and the Centers for Disease Control and Prevention (CDC) for pregnant people to get vaccinated, COVID-19 vaccine hesitancy in pregnancy remains a significant public health problem. The emergence of the highly transmissible B.1.617.2 (Delta) variant among primarily unvaccinated people has exposed the cost of vaccine hesitancy. In this commentary, we explore factors contributing to COVID-19 vaccine hesitancy in pregnancy and potential solutions to overcome them. KEY POINTS: · Low COVID-19 vaccination coverage in pregnant people is a major public health problem in the United States.. · COVID-19 vaccine hesitancy in pregnancy is multifactorial.. · The "4 Cs" framework may be useful in countering COVID-19 vaccine hesitancy..

Publication types

  • Research Support, Non-U.S. Gov't
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Infectious* / prevention & control
  • SARS-CoV-2
  • United States
  • Vaccination
  • Vaccination Hesitancy

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants